Chemogenomic Screening in a Patient-Derived 3D Fatty Liver Disease Model Reveals the CHRM1-TRPM8 Axis as a Novel Module for Targeted Intervention.
Youhanna S, Kemas AM, Wright SC, Zhong Y, Klumpp B, Klein K, Motso A, Michel M, Ziegler N, Shang M, Sabatier P, Kannt A, Sheng H, Oliva-Vilarnau N, Büttner FA, Seashore-Ludlow B, Schreiner J, Windbergs M, Cornillet M, Björkström NK, Hülsmeier AJ, Hornemann T, Olsen JV, Wang Y, Gramignoli R, Sundström M, Lauschke VM.
Youhanna S, et al. Among authors: ziegler n.
Adv Sci (Weinh). 2025 Jan;12(3):e2407572. doi: 10.1002/advs.202407572. Epub 2024 Nov 28.
Adv Sci (Weinh). 2025.
PMID: 39605182
Free PMC article.